196 related articles for article (PubMed ID: 36206383)
1. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
Erton ZB; K Leaf R; de Andrade D; Clarke AE; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Atsumi T; Zhang Z; Cohen H; Ramires de Jesús G; Branch DW; Wahl D; Andreoli L; Rodriguez-Almaraz E; Petri M; Barilaro G; Zuo Y; Artim-Esen B; Willis R; Quintana R; Vendramini MB; Barber MW; Bertolaccini ML; Roubey R; Erkan D
Lupus; 2022 Dec; 31(14):1770-1776. PubMed ID: 36206383
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
Sevim E; Zisa D; Andrade D; Sciascia S; Pengo V; Tektonidou MG; Ugarte A; Gerosa M; Belmont HM; Zamorano MAA; Fortin PR; Ji L; Efthymiou M; Cohen H; Branch DW; de Jesus GR; Andreoli L; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Roubey R; Bertolaccini ML; Erkan D; Barbhaiya M;
Arthritis Care Res (Hoboken); 2022 Feb; 74(2):324-335. PubMed ID: 32986935
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
[No Abstract] [Full Text] [Related]
5. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
de Azevedo Lopes E; Balbi GGM; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Ji L; Cohen H; de Jesús GR; Branch DW; Nalli C; Petri M; Rodriguez E; Kello N; Ríos-Garcés R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Erkan D; Andrade D;
Adv Rheumatol; 2021 Oct; 61(1):64. PubMed ID: 34711275
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
8. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML;
Thromb Res; 2019 Mar; 175():32-36. PubMed ID: 30685523
[TBL] [Abstract][Full Text] [Related]
9. AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.
Barbhaiya M; Andrade D; Erkan D;
Curr Rheumatol Rep; 2016 Oct; 18(10):64. PubMed ID: 27646150
[TBL] [Abstract][Full Text] [Related]
10. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E
Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
[TBL] [Abstract][Full Text] [Related]
12. Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Balbi GGM; Ahmadzadeh Y; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Lopez-Pedrera C; Fortin PR; Wahl D; Gerosa M; de Jesús GR; Ji L; Atsumi T; Efthymiou M; Branch DW; Nalli C; Rodriguez Almaraz E; Petri M; Cervera R; Knight JS; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Roubey R; Erkan D; de Andrade DCO;
Rheumatology (Oxford); 2024 Mar; 63(3):772-779. PubMed ID: 37307082
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
Erton ZB; Sevim E; de Jesús GR; Cervera R; Ji L; Pengo V; Ugarte A; Andrade D; Andreoli L; Atsumi T; Fortin PR; Gerosa M; Zuo Y; Petri M; Sciascia S; Tektonidou MG; Aguirre-Zamorano MA; Branch DW; Erkan D;
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35701043
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
Menet J; Agrinier N; Dufrost V; Conart JB; Wahl D; Duprez KA; Zuily S
Lupus; 2021 Oct; 30(11):1799-1807. PubMed ID: 34284674
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Bernardoff I; Picq A; Loiseau P; Foret T; Dufrost V; Moulinet T; Unlu O; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Jan; 21(1):102913. PubMed ID: 34371159
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
Ma J; Song H; Wei M; He Y
Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
[TBL] [Abstract][Full Text] [Related]
19. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
Front Immunol; 2018; 9():2644. PubMed ID: 30524428
[No Abstract] [Full Text] [Related]
20. Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
Zuo Y; Barbhaiya M; Erkan D
Curr Rheumatol Rep; 2018 Sep; 20(11):66. PubMed ID: 30203272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
